Yesterday, a panel of experts convened by the Food and Drug Administration voted unanimously that halted studies of an experimental class of pain drugs should be restarted, leading to hopes that the drugs might provide another option aside from non-steroidal anti-inflammatory drugs like ibuprofen and naproxen, which may harm the heart or stomach, and opiates ...
FEEDS
